Baytacare Pharmaceutical Co., Ltd. reported consolidated earnings results for the year ended December 31, 2018. For the year, the company reported revenue of RMB 31,925,000 compared to RMB 17,080,000 a year ago. Loss for the year was RMB 114,916,000 compared to RMB 88,420,000 a year ago. Basic loss per share was 13.45 cents compared to 8.58 cents a year ago.